Tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate
C26H30ClN5O4 — CID 142330713
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate
Tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate (PubChem CID 142330713) has the molecular formula C26H30ClN5O4 and a molecular weight of 512.01 g/mol. Its IUPAC name is tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate |
|---|---|
| PubChem CID | 142330713 |
| Molecular Formula | C26H30ClN5O4 |
| Molecular Weight | 512.01 g/mol |
| Exact Mass | 511.20 |
| IUPAC Name | tert-butyl N-[[3-[[2-(2-acetamido-6-methylanilino)pyrimidin-5-yl]oxymethyl]-4-chlorophenyl]methyl]carbamate |
| SMILES | CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2cc(CNC(=O)OC(C)(C)C)ccc2Cl)cn1 |
| InChI | InChI=1S/C26H30ClN5O4/c1-16-7-6-8-22(31-17(2)33)23(16)32-24-28-13-20(14-29-24)35-15-19-11-18(9-10-21(19)27)12-30-25(34)36-26(3,4)5/h6-11,13-14H,12,15H2,1-5H3,(H,30,34)(H,31,33)(H,28,29,32) |
| InChIKey | WNVLBPTYLGYICB-UHFFFAOYSA-N |
| XLogP | 5.74 |
| TPSA | 114.47 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.01 |
| LogP ≤ 5 | 5.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142330713 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.